CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)

Completed

• Conditions: Systemic Lupus Erythematosus

• Registration Number: NCT01520155
• Lead Sponsor: Johann Wolfgang Goethe University Hospital

Brief Summary

The key of this prospective study is to identify a potentially increased cardiovascular risk in patients with systemic Lupus erythematodes, with and without renal affection. Three groups of patients will be compared.

Detailed Description

Key of this prospective study is to identify a potentially increased cardiovascular risk in patients with systemic Lupus erythematodes, with and without renal affection. Three group of patients will be compared as followed. First group are patients with known systemic Lupus erythematodes without renal affection, second group are patients with known systemic Lupus erythematodes with renal affection and the third group are patients with a non-autoimmun chronic kidney disease

Study Timeline

• Study Start: 2011-12
• Study First Submitted: 2011-12-12
• Study First Submitted QC: 2012-01-26
• Study First Posted: 2012-01-27
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2013-12
• Last Update Submitted: 2013-12-20
• Last Update Posted: 2013-12-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Patients with systemic Lupus erythematosus

Exclusion Criteria

• Patients without systemic Lupus erythematosus

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identification of cardiovascular risk in patients with systemic Lupus Erythematodes	one year	Identification of cardiovascular risk in patients with systemic Lupus Erythematodes

Trial Locations

Locations (1)

Frankfurt University Academic Medical Center; 🇩🇪 Frankfurt am Main, Hessen, Germany